As of 2026-10-09, the EV/EBITDA ratio of Treace Medical Concepts Inc (TMCI) is -6.67. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TMCI's latest enterprise value is 297.97 mil USD. TMCI's TTM EBITDA according to its financial statements is -44.69 mil USD. Dividing these 2 quantities gives us the above TMCI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 15.9x | 14.0x |
| Forward P/E multiples | 17.6x - 21.2x | 18.8x |
| Fair Price | (12.82) - (11.67) | (12.05) |
| Upside | -430.7% - -401.2% | -411.0% |
| Date | EV/EBITDA |
| 2026-09-30 | -7.59 |
| 2026-09-29 | -7.75 |
| 2026-09-28 | -7.55 |
| 2026-09-25 | -7.57 |
| 2026-09-24 | -7.63 |
| 2026-09-23 | -7.59 |
| 2026-09-22 | -7.70 |
| 2026-09-21 | -7.55 |
| 2026-09-18 | -7.56 |
| 2026-09-17 | -7.62 |
| 2026-09-16 | -7.66 |
| 2026-09-15 | -7.69 |
| 2026-09-14 | -7.76 |
| 2026-09-11 | -7.59 |
| 2026-09-10 | -7.36 |
| 2026-09-09 | -7.62 |
| 2026-09-08 | -7.76 |
| 2026-09-04 | -8.02 |
| 2026-09-03 | -8.13 |
| 2026-09-02 | -7.86 |
| 2026-09-01 | -7.72 |
| 2026-08-31 | -7.86 |
| 2026-08-28 | -7.79 |
| 2026-08-27 | -7.72 |
| 2026-08-26 | -7.89 |
| 2026-08-25 | -8.02 |
| 2026-08-24 | -7.39 |
| 2026-08-21 | -7.34 |
| 2026-08-20 | -7.52 |
| 2026-08-19 | -7.66 |
| 2026-08-18 | -7.50 |
| 2026-08-17 | -7.57 |
| 2026-08-14 | -8.00 |
| 2026-08-13 | -7.59 |
| 2026-08-12 | -7.94 |
| 2026-08-11 | -7.92 |
| 2026-08-10 | -7.82 |
| 2026-08-07 | -7.95 |
| 2026-08-06 | -7.40 |
| 2026-08-05 | -7.98 |
| 2026-08-04 | -7.92 |
| 2026-08-03 | -7.84 |
| 2026-07-31 | -7.30 |
| 2026-07-30 | -7.40 |
| 2026-07-29 | -6.91 |
| 2026-07-28 | -6.86 |
| 2026-07-27 | -6.96 |
| 2026-07-24 | -6.85 |
| 2026-07-23 | -6.92 |
| 2026-07-22 | -6.80 |